26 October 2020 Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy read more
26 October 2020 Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0 read more
20 October 2020 Praxis Precision Medicines Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares read more
16 October 2020 Praxis Precision Medicines Announces Pricing of Upsized Initial Public Offering read more
14 October 2020 Kronos Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares read more